Angiodynamics Inc (ANGO) 16.54 $ANGO 47.2% Return Seen

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Angiodynamics Inc (ANGO) 16.54 $ANGO

47.2% Return Seen to Date on SmarTrend Angiodynamics Call (ANGO)
Comtex SmarTrend(R) - Wed Aug 31, 12:17AM CDT
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on March 7th, 2016 at $11.40. In approximately 6 months, Angiodynamics has returned 47.17% as of today's recent price of $16.77.
ANGO: 16.54 (-0.23)

Angiodynamics Shares Up 45.1% Since SmarTrend's Buy Recommendation (ANGO)
Comtex SmarTrend(R) - Tue Aug 23, 12:41PM CDT
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on March 7th, 2016 at $11.40. In approximately 6 months, Angiodynamics has returned 45.06% as of today's recent price of $16.53.
ANGO: 16.54 (-0.23)

Angiodynamics Up 40.3% Since SmarTrend Uptrend Call (ANGO)
Comtex SmarTrend(R) - Tue Aug 16, 12:26AM CDT
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on March 7th, 2016 at $11.40. In approximately 5 months, Angiodynamics has returned 40.32% as of today's recent price of $15.99.
ANGO: 16.54 (-0.23)

AngioDynamics to Present at the 2016 Canaccord Genuity Growth Conference
GlobeNewswire - Mon Aug 08, 1:30PM CDT
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer, President and Chief Executive Officer, is scheduled to present at the 2016 Canaccord Genuity Growth Conference on Wednesday, August 10, 2016, at 4:30 p.m. ET. The conference will be held at the InterContinental in Boston, Mass.
ANGO: 16.54 (-0.23)

34.8% Return Seen to Date on SmarTrend Angiodynamics Call (ANGO)
Comtex SmarTrend(R) - Mon Aug 08, 1:01PM CDT
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on March 7th, 2016 at $11.40. In approximately 5 months, Angiodynamics has returned 34.84% as of today's recent price of $15.37.
ANGO: 16.54 (-0.23)

AngioDynamics Announces Secondary Offering of 2,250,000 Shares of Common Stock by Selling Stockholders
GlobeNewswire - Mon Aug 01, 3:30PM CDT
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that Avista Capital Partners, LP and affiliated investment funds intend to offer for sale 2,250,000 shares of common stock in an underwritten secondary offering, pursuant to the Company's shelf registration statement filed with the Securities and Exchange Commission ("SEC". The selling shareholders will receive all of the net proceeds from the offering. AngioDynamics is not selling any common shares in the offering and will not receive any of the proceeds. Cantor Fitzgerald & Co. will act as underwriter for the offering.
ANGO: 16.54 (-0.23)

Shares of ANGO Up 46.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jul 29, 12:39PM CDT
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on March 7th, 2016 at $11.40. In approximately 5 months, Angiodynamics has returned 46.20% as of today's recent price of $16.66.
ANGO: 16.54 (-0.23)

PAVmed Inc. (Nasdaq: PAVMU) to Ring The Nasdaq Stock Market Opening Bell
GlobeNewswire - Thu Apr 28, 11:09AM CDT
What:
PAVMU: 14.53 (+0.23), ANGO: 16.54 (-0.23), NDAQ: 71.21 (-0.13)

AngioDynamics Tops Q3 Earnings, Sales; FY16 View Pruned
Zacks Equity Research - Zacks Investment Research - Fri Apr 08, 9:00AM CDT
AngioDynamics Inc. (ANGO) reported adjusted earnings of 15 cents per share in the third quarter of fiscal 2016, which beat the Zacks Consensus Estimate by a couple cents.
LMAT: 18.38 (-0.08), AMAG: 23.83 (-0.06), ANGO: 16.54 (-0.23), OFIX: 45.11 (+0.52)

Natus Medical: A Strong Sell on Weak Q1 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 12:00PM CDT
On Apr 7, Zacks Investment Research downgraded Natus Medical Inc (BABY) to a Zacks Rank #5 (Strong Sell).
BABY: 38.91 (-0.62), GMED: 23.23 (+0.15), ARAY: 5.33 (-0.03), ANGO: 16.54 (-0.23)

Mazor Robotics Receives 5 Orders in Q1, Shares Down
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 12:20PM CDT
Shares of Mazor Robotics Ltd. (MZOR) fell 4.1% to close at $11.60 on Apr 5, after the company announced the receipt of five orders for Renaissance system.
GMED: 23.23 (+0.15), MZOR: 22.38 (-0.44), ARAY: 5.33 (-0.03), ANGO: 16.54 (-0.23)

Downgrade Alert for Angiodynamics (ANGO)
Comtex SmarTrend(R) - Wed Apr 06, 3:16AM CDT
Angiodynamics (NASDAQ:ANGO) was downgraded from Buy to Hold at Canaccord Genuity today. The stock closed yesterday at $11.07 on volume of 222,000 shares, above average daily volume of 75,000. AngioDynamics, Inc. designs, develops, manufactures, and markets therapeutic and diagnostic devices. The Company's products enable interventional physicians to treat peripheral vascular disease and other non-coronary diseases. AngioDynamic's product lines consist of angiographic catheters, hemodialysis catheters, image guided vascular access products, and thrombolytic products.
ANGO: 16.54 (-0.23)

Can the Uptrend Continue for AngioDynamics (ANGO)?
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 8:49AM CDT
Investors certainly have to be happy with AngioDynamics, Inc. (ANGO) and its short term performance
ANGO: 16.54 (-0.23)

AngioDynamics Appoints James C. Clemmer as New President and Chief Executive Officer
GlobeNewswire - Mon Apr 04, 7:00AM CDT
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of James C. Clemmer as the company's new President and Chief Executive Officer, effective April 4, 2016.
ANGO: 16.54 (-0.23)

AngioDynamics to Report Fiscal 2016 Third Quarter Financial Results
GlobeNewswire - Tue Mar 29, 5:30AM CDT
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 third quarter ended February 29, 2016, on Thursday, April 7, 2016, after the close of the U.S. financial markets.
ANGO: 16.54 (-0.23)

AngioDynamics: Health Canada Okays Celerity with Navigation
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 3:20PM CST
AngioDynamics (ANGO) recently announced that Health Canada has approved the company's Celerity PICC Tip Confirmation System with Navigation.
ABMD: 117.94 (-1.40), EXAC: 27.79 (-0.09), LMNX: 21.07 (+0.04), ANGO: 16.54 (-0.23)

Mauna Kea Technologies Announces the Appointment of Joseph DeVivo as a Non-Executive Director
PR Newswire - Mon Jan 11, 11:00AM CST
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced the appointment of Joseph M. DeVivo as a Director. Mr. DeVivo is the President and Chief Executive Officer of AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology.
ANGO: 16.54 (-0.23)

AngioDynamics Q2 Earnings In Line, Sales Top; '16 View Cut
Zacks Equity Research - Zacks Investment Research - Fri Jan 08, 8:20AM CST
AngioDynamics (ANGO) reported adjusted earnings of 14 cents per share in the second quarter of fiscal 2016, which were in line with the Zacks Consensus Estimate but down 17.6% on a year-over-year basis.
CAPR: 3.66 (+0.06), NXTM: 22.86 (-0.24), ABAX: 50.14 (-0.71), ANGO: 16.54 (-0.23)

AngioDynamics Reports Fiscal 2016 Second Quarter Results
GlobeNewswire - Thu Jan 07, 3:01PM CST
-- Net sales of $89.2 million
ANGO: 16.54 (-0.23)

AngioDynamics to Present at the 34th Annual J.P. Morgan Global Healthcare Conference
GlobeNewswire - Mon Jan 04, 5:30AM CST
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph DeVivo, President and Chief Executive Officer, is scheduled to present at the 34 Annual J.P. Morgan Global Healthcare Conference on Wednesday, January 13, 2016, at 5:30 p.m. EST. The conference will be held at the Westin St. Francis in San Francisco, Ca.
JPM: 67.50 (unch), ANGO: 16.54 (-0.23)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 100

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 38

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 71

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 301

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 36

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
Bank Hapoalim's Q3 2026: Steady Growth Amid Challenges

Updated Category News Views 105

Digging Deep into Hapoalim's Recent Results Now ain't this a turn of events? Bank Hapoalim rolls out its numbers for Q3 2026, and while there's no confetti dropping from the ceiling, the numbers are telling their own story. Net profit comes to a solid NIS 2,364 million, but we're looking at a landscape that's not all rose-tinted today. The bank's managed to pull off...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 23

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
The Melt Grabs Top Spot in Burger Ratings War

Updated Category News Views 5

Burger Battle: The Melt Claims Victory When you're in the cutthroat world of fast-casual dining, grabbing the top spot on any list is no small potatoes. The Melt did just that, snatching the title of America’s Highest-Rated Burger Spot. Based on an in-depth analysis of Google and Yelp reviews, folks have spoken, loud and clear, over the past two years. It's a world...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 92

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading

Top 5 Most Recently Viewed Articles

Banco Comercial Português Adresses Legal Risks of FX Mortgages

Updated Category News Views 191

Understanding Legal Risks in FX Mortgage Loans Banco Comercial Português, S.A. is proactive in addressing estimated legal risks associated with the foreign exchange (FX) mortgage loans portfolio managed by Bank Millennium, S.A. This initiative reflects the bank's commitment to stability and customer security amidst a complex financial landscape. Estimated Provisions for...

Continue Reading
Elevating Dating: MillionaireMatch's New Travel Feature

Updated Category News Views 117

Introducing the New Feature on MillionaireMatch MillionaireMatch, the renowned dating website catering to billionaires and successful individuals, has launched an exciting new feature known as 'Willing to Fly to Meet.' This update empowers users to indicate their readiness to travel distances for a potential romantic connection. By opting into this feature, individuals...

Continue Reading
Whistle Design Sparks Innovation for Coaches and Trainers

Updated Category News Views 151

So, here’s the lowdown: a new whistle design is hitting the scene, aiming to make coaches’ calls clearer amidst the chaos of overlapping games. But let’s not get lost in the novelty—this isn’t just about some fancy gadget; it’s got implications worth dissecting. First up, this invention is supposedly patent-pending. That tag usually raises eyebrows in finance...

Continue Reading
UK Imposes Sanctions on Russian Military for Chemical Warfare

Updated Category News Views 119

UK Sanctions Against Russian Military Forces The UK government has taken a bold step to address the ongoing situation in Ukraine by imposing sanctions on Russian military personnel linked to the use of chemical weapons on the battlefield. This decisive action showcases the UK's commitment to upholding international law and protecting human rights. Targeted Sanctions on...

Continue Reading
PepsiCo Prepares for Challenging Q3 Amid Pricing Pressures

Updated Category News Views 296

PepsiCo's Current Market Position PepsiCo, Inc. (NASDAQ: PEP) continues to show resilience as it navigates a complex economic environment. Recently, the company’s shares have been trading slightly higher, reflecting a degree of investor confidence amidst ongoing market challenges. Analyst Insights on Upcoming Earnings According to analyst Peter T. Galbo from BofA...

Continue Reading